Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Kissei Pharmaceutical Co ( (JP:4547) ) has shared an update.
Kissei Pharmaceutical Co., Ltd. has completed the acquisition of 1,369,200 treasury shares, representing 3.20% of its issued shares, for a total cost of 5,216,652,000 yen. This move is part of a flexible capital policy aimed at improving capital efficiency and enhancing shareholder returns, with the acquired shares set to be canceled by June 27, 2025.
More about Kissei Pharmaceutical Co
Kissei Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, focusing on the development and distribution of medical products. The company is listed on the Tokyo Stock Exchange and aims to enhance shareholder value through strategic financial maneuvers.
Average Trading Volume: 72,057
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen160.2B
See more insights into 4547 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue